Autopsy report · NCT02045251

An Open-Label Trial Of Reduced- Dose Pylera, Amoxicillin, and Esomeprazole in the Treatment Of Helicobacter Pylori Infection

“Unavailability of clarithromycin 250 mg in the market”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

American University of Beirut Medical Center

Sponsor type

University, hospital or other

Conditions

Treatment of H. Pylori Infection

Interventions

Pylera based reduced regimen

Participants

0

Sites

1

Countries

Lebanon

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.